Health
Dysregulated cholesterol trafficking through ABCA1 drives neurodegeneration in Parkinson’s disease - Nature

What the report says
This study identifies ABCA1 as a driver of dysregulated cholesterol trafficking in Parkinson’s disease, showing that reducing ABCA1 in astrocytes and neurons decreases cholesterol accumulation, α-synuclein pathology and neurodegeneration in mice.
Loading debate for this article…
Other publishers covering this story
No additional verified coverage is currently clustered with this report.

75% of Cancer Patients in Uganda Seek Treatment at Advanced Stages, Experts WarnNile Post
Benard Feni Joins Malaria Free Uganda Board as Push for Domestic Funding GrowsNile Post
Lango Seeks Japanese Investment in Agriculture, Industry and Social ServicesNile Post
Medicine shortages undermining village health teamsThe Observer
Depression: Walking Through the Three Corners of Life Toward HealingNile Post